ICD-10 Coding for Cervical Intraepithelial Neoplasia Grade III(D06.9)
Complete ICD-10-CM coding and documentation guide for Cervical Intraepithelial Neoplasia Grade III. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Cervical Intraepithelial Neoplasia Grade III
D06Primary Range
Carcinoma in situ of cervix uteri
This range includes codes for cervical intraepithelial neoplasia, specifically CIN III, which is classified as carcinoma in situ.
Dysplasia of cervix uteri
This range includes codes for cervical dysplasia, such as CIN II, which is important for differential diagnosis.
Key Information: ICD-10 code for CIN III
Essential facts and insights about Cervical Intraepithelial Neoplasia Grade III
Primary ICD-10-CM Code for cervical intraepithelial neoplasia-grade iii
Decision Criteria
clinical Criteria
- Histological confirmation of CIN III with p16 positivity.
documentation Criteria
- Explicit mention of CIN III or HSIL (CIN III) in pathology report.
Applicable To
- CIN III
- HSIL (CIN III)
- Severe dysplasia
Excludes
- CIN II (N87.1)
- CIN 2-3 without specification
Clinical Validation Requirements
- Histologically confirmed CIN III
- p16 block-positive staining
Code-Specific Risks
- Incorrectly coding CIN 2-3 as CIN III without confirmation.
Coding Notes
- Ensure documentation explicitly states CIN III or HSIL (CIN III) with supporting histopathology.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Encounter for screening for malignant neoplasm of cervix
Z12.4Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Cervical Intraepithelial Neoplasia Grade III to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D06.9.
Impact
Clinical: Leads to incorrect treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation Strategy
Ensure clear communication with pathologists., Verify documentation before coding.
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation Strategy
Query the provider to confirm if CIN III is present.
Impact
Inaccurate or incomplete documentation of CIN III.
Mitigation Strategy
Implement regular training for providers on documentation standards.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Cervical Intraepithelial Neoplasia Grade III, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Cervical Intraepithelial Neoplasia Grade III
Use these documentation templates to ensure complete and accurate documentation for Cervical Intraepithelial Neoplasia Grade III. These templates include all required elements for proper coding and billing.
Pathology report for CIN III
Specialty: PathologyRequired Elements
- Histological findings
- p16 staining results
- Diagnosis
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Cervical Intraepithelial Neoplasia Grade III? Ask your questions below.